Beneficial effects of tibolone on blood pressure and liver redox status in ovariectomized rats with renovascular hypertension

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 5, 2013, Pages 510-520

  Gilglioni, Eduardo Hideo ^a   Campos, Lilian Brites ^a   Oliveira, Monique Cristine ^b   Garcia, Rosângela Fernandes ^a   Ambiel, Célia Regina ^a   Buzzo, Ana Julia Dos Reis ^a   Ishii Iwamoto, Emy Luzia ^b   Salgueiro Pagadigorria, Clairce Luzia ^a,b  

^a Department of Physiological Science ^*  (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Estrogen deficiency; Hypertension; Liver lipid metabolism; Liver redox status; Tibolone.

Indexed keywords

RATTUS;

ANTIHYPERTENSIVE AGENT; PREGNANE DERIVATIVE; TIBOLONE;

ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; FEMALE; LIVER; METABOLISM; OVARIECTOMY; OXIDATION REDUCTION REACTION; RAT; RENOVASCULAR HYPERTENSION; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HYPERTENSION, RENOVASCULAR; LIVER; NORPREGNENES; OVARIECTOMY; OXIDATION-REDUCTION; RATS; RATS, WISTAR;

MLCS; MLOWN;

EID: 84876242634     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls210     Document Type: Article

References (54)

1. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hyperten-sion: an age-old debate. Hypertension. 2008;51:952-959.
2. Rappelli A. Hypertension and obesity after the menopause. J Hypertens Suppl. 2002;20:S26-S28.
3. Reckelhoff JF, Fortepiani LA. novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004;43:918-923.
4. Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas. 1998;30:295-305.
5. Morley JE, Perry HM III. Androgens and women at the menopause and beyond. J Gerontol a Biol Sci Med Sci. 2003;58:M409-M416.
6. Hänggi W, Lippuner K, Jaeger P, Birkhäuser MH, Horber FF. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmeno-pausal women. clin endocrinol (oxf). 1998;48:691-699.
7. Henriques Hn, Câmara nR, de Carvalho AC, Pantaleão JA, Guzmán-Silva MA. [Effect of high doses of tibolone in body weight and lipid pro-fle of ovariectomized rats]. Rev Bras Ginecol obstet. 2010;32:88-93.
8. Pytlik M. Effects of tibolone on the development of osteopenia induced by ovariectomy in rats. Pol J Pharmacol. 2002;54:35-43.
9. Farish E, Fletcher CD, Hart DM, Lindsay R, Leggate J. Org OD 14: long-term effects on serum lipoproteins. Maturitas. 1984;6:297-299.
10. Yoshitake K, Yokota K, Kasugai Y, Kagawa M, Sukamoto T, nakamura T. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariecto-mized rats with established osteopenia on a low-calcium diet. Bone. 1999;25:311-319.
11. Crona n, Silfverstolpe G, Samsioe G. A double-blind cross-over study on the effects of ORG OD14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women. acta endocrinol. 1983;102:451-455.
12. Vassalle C, Cicinelli E, Lello S, Mercuri A, Battaglia D, Maffei S. Effects of menopause and tibolone on different cardiovascular bio-markers in healthy women. Gynecol endocrinol. 2011;27:163-169.
13. Haenggi W, Bersinger nA, Mueller MD, Birkhaeuser MH. Decrease of serum endothelin levels with postmenopausal hormone replace-ment therapy or tibolone. Gynecol endocrinol. 1999;13:202-205.
14. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. the production of persistent elevation of systolic blood pressure by means of renal ischemia. J exp Med. 1934;59:347-379.
15. Czerny B, Teister M, Juzyszyn Z, Mysliwiec Z, Pawlik A. Effect of tibolone on turnover of cholesterol to bile acids in ovariectomized rats. Menopause. 2005;12:609-612.
16. de Oliveira MC, Martins-Maciel ER, Comar JF, et al. Tibolone impairs glucose and fatty acid metabolism and induces oxidative stress in livers from female rats. eur J Pharmacol. 2011;668:248-256.
17. Matthews DR, Hosker JP, Rudenski AS, naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentra-tions in man. Diabetologia. 1985;28:412-419.
18. Folch J, Lees M, Sloane Stanley GH. A simple method for the isola-tion and purifcation of total lipides from animal tissues. J Biol chem. 1957;226:497-509.
19. Bracht A, Ishii-Iwamoto EL, Salgueiro-Pagadigorria, CL. Técnica de centrifugação e fracionamento celular. In: Bracht A, Ishii-Iwamoto EL, eds. Métodos de laboratório em Bioquímica. São Paulo, Brazil: Manole Ltda.; 2003: 77-101.
20. natarajan SK, Eapen CE, Pullimood AB, Balasubramanian KA. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatol. 2006;21: 1240-1249.
21. Lowry OH, Rosebrough nJ, Farr AL, Randall RJ. Protein measure-ment with the Folin phenol reagent. J Biol chem. 1951;193:265-275.
22. Garland PB, Shepherd D, nicholls DG, Yates DW, Light PA. Interactions between fatty acid oxidation and the tricarboxylic acid cycle. In: Lowestein JM, ed. citric acid cycle. new York, nY: Marcel Dekker; 1969:163-212.
23. Taguchi H, Ogura Y, Takanashi T, Hashizoe M, Honda Y. In vivo quan-titation of peroxides in the vitreous humor by fuorophotometry. invest ophthalmol Vis Sci. 1996;37:1444-1450.
24. Small GM, Burdett K, Connock MJ. A sensitive spectropho-tometric assay for peroxisomal acyl-CoA oxidase. Biochem J. 1985;227:205-210.
25. Aebi, H. Catalase. In: Bergmeyer HU, ed. Methods of enzymatic analysis. new York, nY: Academic Press; 1974:673-690.
26. Berson A, De Beco V, Lettéron P, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepato-cytes. Gastroenterology. 1998; 114:764-774.
27. Hissin PJ, Hilf R. A fuorometric method for determination of oxidized and reduced glutathione in tissues. anal Biochem. 1976;74:214-226.
28. Ohkawa H, Ohishi n, Yagi K. Assay for lipid peroxides in animal tis-sues by thiobarbituric acid reaction. anal Biochem. 1979;95:351-358.
29. Mize CE, Langdon RG. Hepatic glutathione reductase. I. Purifcation and general kinetic properties. J Biol chem. 1962;237:1589-1595.
30. Paglia DE, Valentine Wn. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J lab clin Med. 1967;70:158-169.
31. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. eur J Biochem. 1974;47:469-474.
32. Tian Wn, Pignatare Jn, Stanton RC. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydroge-nase from permeabilized cells. J Biol chem. 1994;269:14798-14805.
33. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver dis-ease. Diabet Med. 2005;22:1129-1133.
34. Reddy JK, Mannaerts GP. Peroxisomal lipid metabolism. annu Rev nutr. 1994;14:343-370.
35. Appt SE, Tormala R, Franke AA, et al. Soy-Tibolone combination\- effect on lipid in postmenopausal monkeys and women. eur Menop J. 2008; 60:216-222.
36. Uhler ML, Marks JW, Judd HL. Estrogen replacement therapy and gall-bladder disease in postmenopausal women. Menopause. 2000;7:162-167.
37. Simoncini T, Mannella P, Fornari L, et al. Tibolone activates nitric oxide synthesis in human endothelial cells. J clin endocrinol Metab. 2004;89:4594-4600.
38. Seeger H, Kloosterboer HJ, Studen M, Wallwiener D, Mueck AO. In vitro effects of tibolone and its metabolites on human vascular coro-nary cells. Maturitas. 2007;58:42-49.
39. Dedeoǧlu En, Erenus M, Yörük P. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmeno-pausal women. Fertil Steril. 2009;91:425-431.
40. Gol M, Ozsener S, Uretmen FSS, Oztekin K, Bilgim TTO. Does tibo-lone affect serum leptin levels and body weight in postmenopausal women? arch Gynecol obstet. 2005; 272:127-130.
41. Bianco V, Murina F, Roberti P, Valente I. Tibolone in the treatment of menopause: compliance, effcacy and safety in a ten year experience. Minerva Ginecol. 2006;58:335-344.
42. Van Sinderen ML, Boon WC, Ederveen AG, Kloosterboer HJ, Simpson ER, Jones ME. The estrogenic component of tibolone reduces adiposity in female aromatase knockout mice. Menopause. 2009;16:582-588.
43. Paquette A, Shinoda M, Rabasa Lhoret R, Prud'homme D, Lavoie JM. Time course of liver lipid infltration in ovariectomized rats: impact of a high-fat diet. Maturitas. 2007;58:182-190.
44. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol chem. 2005;280:35983-35991.
45. Völzke H, Schwarz S, Baumeister SE, et al. Menopausal status and hepatic steatosis in a general female population. Gut. 2007;56: 594-595.
46. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP. Relationship between oxidative stress and essential hypertension. Hypertens Res. 2007;30:1159-1167.
47. Behl C, Skutella T, Lezoualc'h F, et al. neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol. 1997;51:535-541.
48. Park J, Choe SS, Choi AH, et al. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and infam-matory signals. Diabetes. 2006;55:2939-2949.
49. Borras C, Gambini J, Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci. 2007;12:1008-1013.
50. Kumar S, Lata K, Mukhopadhyay S, Mukherjee TK. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective. Biochim Biophys acta. 2010;1800:1127-1135.
51. Fee JA. Is superoxide toxic? In: Bannister WH, Bannister JV, eds. Biological and clinical aspects of Superoxide and Superoxide Dismutase. new York, nY: Elsevier/north Holland; 1982:41-48.
52. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell sign-aling. am J Physiol lung cell Mol Physiol. 2000;279:L1005-L1028.
53. Ibim SE, Randall R, Han P, Musey PI. Modulation of hepatic glucose-6-phosphate dehydrogenase activity in male and female rats by estro-gen. life Sci. 1989;45:1559-1565.
54. Kankofer M, Radzki RP, Bieńko M, Albera E. Anti-oxidative/ oxidative status of rat liver after ovariectomy J Vet Med a Physiol Pathol clin Med. 2007;54:225-229.